Related Experiment Video

Updated: May 18, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

[The course and treatment of epilepsy in children with tuberose sclerosis]

M Iu Dorofeeva, E D Belousova

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |September 18, 2012
    PubMed

    Insights

    Tuberous sclerosis complex (TSC) is a genetic disorder where epilepsy affects most individuals. Vigabatrin is effective for infantile spasms in TSC patients.

    Area of Science:

    • Genetics
    • Neurology
    • Pediatrics

    Background:

    • Tuberous sclerosis complex (TSC) is a multisystem genetic disorder.
    • Epilepsy is a prevalent manifestation, affecting 75-92% of individuals with TSC.
    • Infantile spasms occur in up to one-third of children with TSC, often presenting in childhood.

    Purpose of the Study:

    • To summarize the challenges and treatment approaches for epilepsy in Tuberous Sclerosis Complex.
    • To highlight the significance of resistant epilepsy, cognitive, and behavioral issues in TSC management.
    • To review current therapeutic strategies for epilepsy associated with TSC.

    Main Methods:

    • Literature review of epilepsy management in Tuberous Sclerosis Complex.
    • Analysis of treatment options including anticonvulsant medications, epilepsy surgery, vagus nerve stimulation, and ketogenic diet.
    • Evaluation of specific drug efficacy for TSC-related epilepsy.

    Main Results:

    • Epilepsy is a major concern in TSC, impacting quality of life for patients and families.
    • Standard epilepsy treatments are applicable, but resistant epilepsy is common.
    • Vigabatrin demonstrates particular effectiveness in treating infantile spasms in the context of TSC.

    Conclusions:

    • Epilepsy management in TSC requires a comprehensive approach.
    • Vigabatrin is a key therapeutic option for infantile spasms in TSC.
    • Addressing cognitive and behavioral issues alongside epilepsy is crucial for holistic TSC care.

    More Related Videos

    Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe06:04

    Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

    Published on: August 16, 2024

    Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients09:32

    Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

    Published on: December 18, 2016

    Related Concept Videos

    Epilepsy ll: Types01:22

    Epilepsy ll: Types

    Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
    Seizures: Classification01:13

    Seizures: Classification

    Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
    Seizures are typically classified into two main categories: focal and generalized seizures.
    Focal Seizures
    Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    Electroconvulsive Therapy01:30

    Electroconvulsive Therapy

    Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
    Seizures l: Introduction01:20

    Seizures l: Introduction

    Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
    Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

    Antiepileptic Drugs: GABAergic Pathway Potentiators

    γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
    The key GABA pathway potentiators used in epilepsy management are as follows.
    Benzodiazepines are a well-known class of drugs used for their...